focus -WSS

focus

author：hotspot 2025-09-27 15:58:57 - browse：22

A sign of Elevance Health behind some flowers — coverage from STAT — Michael Conroy/AP

Paul Marchetti, the head of insurer Elevance Health’s pharmacy benefit manager, has left the company amid a wave of consumer complaints about patients receiving incorrect medicines or being unable to get their prescriptions filled.

Elevance did not confirm Marchetti’s departure as the president of CarelonRx, but according to his Linkedin profile, he left the company in May.

Elevance, the second-largest commercial health insurer in the country by market share, uses its CarelonRx subsidiary to manage its pharmacy business. In online complaints, CarelonRx customers point toward January 1 as the date when issues with obtaining their prescriptions from the company began. The reported problems include safety issues like receiving other people’s medications or receiving medications they discontinued years ago.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： CDC: Uninsured rate hit 'record low' right as states cut Medicaid

WSS

2 US Navy sailors arrested for allegedly spying for China

TytoCare raises $49 million to build out AI

Dramatically reducing cancer deaths requires the PASTEUR Act

Stanford president to resign after investigation of research

Why some people catch Covid but never get sick

For BCIs, commercial hurdles may be bigger than scientific ones

leisure time

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily market-moving biopharma analysis — by subscribing to STAT+.

hotspot

Hepatitis C has a cure — but many Americans still lack access to it

What Henrietta Lacks settlement says about racism in medicine

United colonoscopy coverage change 'may cost lives,' doctors say

Attacks on the drug industry will lead to fewer breakthroughs

Heart attack and stroke risk calculators need revising

Norman Reedus' Daryl Dixon

Apple is now the first public company to be valued at $3 trillion

The drug industry sees a key ally in the Senate prevail

ChatGPT in medicine: STAT answers readers' burning questions

For BCIs, commercial hurdles may be bigger than scientific ones

Wikipedia

Plane’s emergency slide plummets from sky, hits Chicago home

Microsoft strikes partnership with Duke Health to advance health AI

Trump got a 'target letter.' What is one and what does it mean?

Seattle police shoot person suspected in downtown stabbing

States increasingly look to regulate hospital facility fees

My superpower is killing ticks

explore

hotspot

hotspot

focus